Researchers in Democratic congressional districts stand to have $2.1 billion in NIH grants reinstated, compared to $62 million in Republican districts.

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s stance on vaccines ...

Markets Company Close Updates Company Close Updates Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day By MarketWatch Automation Published: July 2, 2025, 4:46 p.m ...

By Colin Kellaher Regeneron Pharmaceuticals has won Food and Drug Administration accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.

Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.

Regeneron secured accelerated FDA approval for Lynozyfic, a therapy targeting relapsed or refractory multiple myeloma. The drug is approved for patients who’ve tried at least four previous treatments, ...

Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today by Benzinga Insights Benzinga Staff Writer Follow Add Comment ...

Bessemer Group significantly trimmed its investment in Regeneron Pharmaceuticals during the first quarter, slashing its stake by 76%. The firm sold 3,860 shares, reducing its position to just 1,218 ...

Regeneron will announce Q2 2025 results on August 1, 2025, and host a conference call at 8:30 AM ET. Regeneron Pharmaceuticals, Inc. announced that it will disclose its second quarter 2025 ...